A new in vitro assay for quantitation of chemotherapy-induced mucositis
1997

New Test for Measuring Chemotherapy-Induced Mouth Sores

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): ANM Wymenga, WTA van der Graaf, FLK Spijkervet, W Timens, H Timmer-Bosscha, WJ Sluiter, EGE de Vries, NH Mulder

Primary Institution: University Hospital Groningen

Hypothesis

The study aimed to develop an objective in vitro assay for quantifying chemotherapy-induced mucositis.

Conclusion

The study found that after high-dose chemotherapy, the percentage of viable oral epithelial cells increases, indicating that the new assay may be more sensitive than traditional scoring systems.

Supporting Evidence

  • The percentage of viable oral epithelial cells increased significantly after day 7 compared to pretreatment.
  • A shift from mature to immature epithelial cells was observed in buccal smears after chemotherapy.
  • The WHO score followed the results of other evaluations with some delay.

Takeaway

Doctors can now use a new test to measure how chemotherapy affects the mouth, which helps in preventing painful mouth sores.

Methodology

The study involved 12 patients receiving high-dose chemotherapy, with evaluations of oral mucosa through oral washings and buccal smears before and after treatment.

Limitations

The study had a small sample size and was limited to patients with locally advanced breast carcinoma.

Participant Demographics

Patients had a mean age of 44 years, with a range from 24 to 53 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 0.01-0.03 x 10^9 1-1

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication